Y-Intercept (HK)’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.1K | Buy |
+52,521
| New | +$75.1K | ﹤0.01% | 1551 |
|
|
2025
Q1 | – | Sell |
-23,176
| Closed | -$83.4K | – | 1236 |
|
|
2024
Q4 | $83.4K | Buy |
+23,176
| New | +$83.4K | 0.01% | 1107 |
|
|
2024
Q1 | – | Sell |
-18,823
| Closed | -$106K | – | 1397 |
|
|
2023
Q4 | $106K | Buy |
+18,823
| New | +$106K | 0.01% | 1089 |
|
|
2023
Q3 | – | Sell |
-75,900
| Closed | -$209K | – | 1104 |
|
|
2023
Q2 | $209K | Buy |
75,900
+44,538
| +142% | +$122K | 0.02% | 926 |
|
|
2023
Q1 | $98.5K | Buy |
+31,362
| New | +$98.5K | 0.01% | 1057 |
|